Home›Companies›Healthcare›Endolynx

Endolynx Inc.

Updated Oct 29, 2026·Latest SEC filing Mar 6, 2023·Suggest an edit

About Endolynx

Endolynx is a private company based in Jersey City, New Jersey. It has reported $30,000 raised in one offering on Form D since March 2023.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Nov 4, 2021Mar 6, 2023$30,000fully sold3$10,000OptionsRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Endolynx's Form D filed Mar 6, 2023.

RJ
Robert Jenkins
Executive officer and director
FJ
Felek Jachimowicz
Executive officer and director
DS
David Schaner
President and director

Sources

  1. SECEndolynx Inc. filing history